Atlas Trials

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Clinical trial NCT01396291 · COMPLETED

Trial details

NCT number
NCT01396291
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar 1 Disorder
Start date
2011-12-01
Primary completion
2015-04-01
Enrollment
561

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.